CATTLE HEALTHCARE MARKET ANALYSIS

Cattle Healthcare Market By Product (Vaccine, Parasiticide, Anti-infective, Medical Feed Additive, & Other Pharmaceuticals), By Diagnostic Type (Immunodiagnostic Test, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, and Other Veterinary Diagnostics), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Nov 2022
Code : CMI5347
Pages :165
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Cattle Healthcare Market: Key Companies Insights

The global cattle healthcare market is highly competitive. This is attributed to the rise in demand for vaccination due to increase burden of infectious diseases, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global cattle healthcare market are Idexx Laboratories, Boehringer Ingelheim, Virbac, Elanco, IDVet, Zoetis Inc., Bayer Healthcare, Merck & Co. Inc., and Ceva Animal Health Inc., among others.”

Global Cattle Healthcare Market: Key Developments

In July 2020, Merck Animal Health ramped up its animal vaccine production capacity with a USD 100 million investment in its Kansas manufacturing site.

In July 2017, Bayer AG expanded its Animal Health Business investing around EUR 92 million for the further development of the production site in Kiel.